← Scroll for more →
Financial Statements — CRWV
Balance Sheet
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.52 | 2.24 | 1.89 | 1.15 | 1.28 |
| Short-term Investments | 0.02 | 0.02 | 0.05 | -- | -- |
| Accounts Receivable | 2.54 | 2.12 | 1.66 | 1.93 | 1.06 |
| Total Current Assets | 9.52 | 5.61 | 4.73 | 3.95 | 3.10 |
| Property, Plant & Equipment | 46.74 | 36.42 | 20.66 | 16.63 | 14.21 |
| Goodwill | 1.10 | 1.10 | 0.83 | 0.81 | 0.02 |
| Intangible Assets | 0.22 | 0.22 | 0.20 | 0.21 | 0.00 |
| Total Non-current Assets* | 67.55 | 49.96 | 28.18 | 22.30 | 18.76 |
| Total Assets | 77.07 | 55.57 | 32.91 | 26.24 | 21.86 |
| Accounts Payable | 3.63 | 3.37 | 1.16 | 1.23 | 1.24 |
| Total Current Liabilities | 20.92 | 17.82 | 9.71 | 7.56 | 7.13 |
| Long-term Debt | -- | 24.86 | 14.03 | 11.05 | 8.71 |
| Total Non-current Liabilities* | 51.13 | 33.00 | 19.32 | 14.86 | 11.66 |
| Total Liabilities | 72.05 | 50.81 | 29.03 | 22.42 | 18.79 |
| Retained Earnings | (4.01) | (3.38) | (2.19) | (2.08) | (1.79) |
| Total Stockholder Equity | 5.02 | 4.76 | 3.88 | 2.66 | 1.91 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total Revenue | 2.58 | 2.08 | 1.57 | 1.36 | 1.21 | 0.98 |
| Cost of Revenue | 0.88 | 0.72 | 0.51 | 0.37 | 0.31 | 0.26 |
| Gross Profit | 1.70 | 1.36 | 1.06 | 1.00 | 0.90 | 0.72 |
| Research & Development | 0.12 | 0.10 | 0.11 | 0.09 | 0.08 | 0.07 |
| Selling, General & Admin | 0.18 | 0.16 | 0.15 | 0.15 | 0.17 | 0.17 |
| Total Operating Expenses | 1.75 | 1.51 | 1.15 | 0.94 | 0.88 | 0.75 |
| Operating Income | (0.05) | (0.14) | (0.09) | 0.05 | 0.02 | (0.03) |
| Pretax Income | (0.56) | (0.66) | (0.47) | (0.24) | (0.24) | (0.27) |
| Tax Provision | 0.06 | 0.08 | (0.02) | (0.13) | 0.05 | 0.05 |
| Net Income | (0.63) | (0.74) | (0.45) | (0.11) | (0.29) | (0.31) |
| Basic EPS | (1.14) | (1.40) | (0.53) | (0.22) | (0.60) | (1.40) |
| Diluted EPS | (1.14) | (1.40) | (0.50) | (0.22) | (0.60) | (1.49) |
← Scroll for more columns →
Cash Flow Statement
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.68 | 2.98 | 1.56 | 1.69 | (0.25) | 0.06 |
| Capital Expenditures | 6.42 | 7.70 | 4.06 | 2.39 | 2.45 | 1.41 |
| Free Cash Flow* | (5.74) | (4.71) | (2.50) | (0.70) | (2.70) | (1.35) |
| Investing Cash Flow | (7.17) | (7.71) | (3.93) | (2.47) | (2.44) | (1.43) |
| Financing Cash Flow | 10.07 | 3.91 | 3.53 | 1.70 | 2.23 | 1.85 |
← Scroll for more columns →
* Derived from reported values
Dividends Per Share
(USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Dividends Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
← Scroll for more columns →